Michael Bavand

Michael R. Bavand is a highly experienced professional in the fields of biotechnology and pharmaceutical development, currently serving as a Member of the Board of Directors at Glycocalyx Therapeutics AG and Co-Founder & Chief Technology Officer at Cellula Therapeutics SA. With a robust background as an Entrepreneur & CTO at Remora Biotech, Bavand has been instrumental in translating scientific innovations into therapies across immunology and oncology. Previous roles include President & CEO of ChromaCon, Director of Technology & Operations at Kuros Biosciences, and Founder of Siegfried Biologics. Academic credentials include a Dr. sci.nat. in Biochemistry from ETH Zürich and Executive Education from Stanford University Graduate School of Business and Harvard Business School.